Youth Climate Activists Expand Their Focus and Collaborate to Get Out the Vote

Youth Climate Activists Expand Their Focus and Collaborate to Get Out the Vote

Young climate activists from left: Saad Amer, Isha Clarke, and Benji Backer.

Photos by Cassell Ferere, Sunshine Velasco, and Conor Courtney.

This article is part of the magazine, "The Future of Science In America: The Election Issue," co-published by LeapsMag, the Aspen Institute Science & Society Program, and GOOD.

For youth climate activists, Earth Day 2020 was going to be epic. Fueled by the global climate strikes that drew millions of young people into streets around the world in 2019, the holiday's historic 50th anniversary held the promise of unprecedented participation and enthusiasm.

Then the pandemic hit. When the ability to hold large gatherings came to a screeching halt in March, just a handful of weeks before Earth Day, events and marches were cancelled. Activists rallied as best they could and managed to pull off an impressive three-day livestream event online, but like everything we've experienced since COVID-19 arrived, it wasn't the same.

Add on climate-focused candidate Bernie Sanders dropping out of the U.S. presidential race in April, and the spring of 2020 was a tough time for youth climate activists. "We just really felt like there was this energy sucked out of the movement," says Katie Eder, 19-year-old founder and Executive Director of Future Coalition. "And there was a lot of cynicism around the election."

Keep Reading Keep Reading
Annie Reneau
Annie is a writer, wife, and mother of three with a penchant for coffee, wanderlust, and practical idealism. On good days, she enjoys the beautiful struggle of maintaining a well-balanced life. On bad days, she binges on chocolate and dreams of traveling the world alone.
Get our top stories twice a month
Follow us on
The Friday Five: Soon Band-Aids Could Be AIs

In this week's Friday Five, research on a "smart" bandage for wounds, a breakthrough in fighting inflammation, the pros and cons of a new drug for Alzheimer's, benefits of the Mediterranean diet with a twist, and we've learned to recycle a plastic that was un-recyclable.

Adobe Stock

The Friday Five covers five stories in research that you may have missed this week. There are plenty of controversies and troubling ethical issues in science – and we get into many of them in our online magazine – but this news roundup focuses on scientific creativity and progress to give you a therapeutic dose of inspiration headed into the weekend.

Keep Reading Keep Reading
Matt Fuchs

Matt Fuchs is the editor-in-chief of Leaps.org. He is also a contributing reporter to the Washington Post and has written for the New York Times, Time Magazine, WIRED and the Washington Post Magazine, among other outlets. Follow him on Twitter @fuchswriter.

Sexually Transmitted Infections are on the rise. This drug could stop them.

Cases of gonorrhea, chlamydia and syphilis soared last year, but researchers are finding that a drug known as doxy seems to reduce the number of infections.

Adobe Stock

Sexually transmitted infections (STIs) are surging across the U.S. to 2.5 million cases in 2021 according to preliminary data from the CDC. A new prevention and treatment strategy now in clinical trials may provide a way to get a handle on them.

It's easy to overlook the soaring rates of gonorrhea, chlamydia, and syphilis because most of those infections have few or no symptoms and can be identified only through testing. But left untreated, they can lead to serious damage to nerves and tissue, resulting in infertility, blindness, and dementia. Infants developing in utero are particularly vulnerable.

Keep Reading Keep Reading
Bob Roehr
Bob Roehr is a biomedical journalist based in Washington, DC. Over the last twenty-five years he has written extensively for The BMJ, Scientific American, PNAS, Proto, and myriad other publications. He is primarily interested in HIV, infectious disease, immunology, and how growing knowledge of the microbiome is changing our understanding of health and disease. He is working on a book about the ways the body can at least partially control HIV and how that has influenced (or not) the search for a treatment and cure.